Back

Hemoglobin value effects of levosimendan in patients with heart failure complicating an acute coronary syndrome

11 May 2024 (10:36 - 12:12)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pathophysiology and mechanisms 2 Cardiotoxicity of Drugs and Other Therapies HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Antonio Rocha De Almeida

Hospital Espirito Santo de Evora, Evora (Portugal)

4 More presentations in this session

Presentation thumbnail
Doxorubicin leads to increased oxidative stress and opening of the calcium-induced mitochondrial permeability transition pore
Mrs M. Denysova (Kiev, UA)
Abstract Slides Video
Presentation thumbnail
The impact of STR in impedance cardiography on cardiovascular mortality among heart failure patients with reduced ejection fraction
Professor S. Charfeddine (Sfax, TN)
Abstract Slides
Presentation thumbnail
Fontan survivors and left ventricular dysfunction in adult patients
Doctor M. Carvalho (Leiria, PT)
Abstract Slides Video
Presentation thumbnail
Spot urinary sodium and its relation to reverse remodelling in new onset heart failure with reduced EF
Doctor M. Ibrahim (Cairo, EG)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - pathophysiology and mechanisms 2

The Event

Event poster

Heart Failure 2024

11 May 2024 10:36 CET
You may be interested in
thumbnail
Congress Presentation
Levosimendan in advanced heart failure: a step forward in functional recovery and hospitalization reduction
30 August 2025
thumbnail
Congress Presentation
Impact of anemia on long-term clinical outcomes in patients with acute myocardial infarction accompanied by cardiogenic shock
13 May 2024
thumbnail
Congress Presentation
Selecting the proper vasoactive drugs
26 March 2023
thumbnail
Congress Session
Advances in cardiomyopathies
11 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources